Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alice J. Canaan"'
Publikováno v:
Biopharmaceutics & Drug Disposition. 19:395-400
Photodynamic therapy (PDT) using the photosensitizer BPD-Verteporfin (liposomal benzoporphyrin derivative-monoacid ring A) has been shown in previous studies to be effective in the amelioration of inflammatory arthritis in both the MRL-lpr mouse and
Publikováno v:
Photochemistry and Photobiology. 62:169-175
Benzoporphyrin derivative monoacid ring A (BPD), a hydrophobic chlorin-like porphyrin derivative, which fluoresces strongly at 690 nm, may have potential for both oncologic and nononcologic applications in photodynamic therapy (PDT). To study the inf
Autor:
Alice J. Canaan, Anna M. Richter, Ashok K. Jain, Elizabeth Waterfield, Beth Anne Allison, Julia G. Levy
Publikováno v:
Photochemistry and Photobiology. 57:1000-1006
Biodistribution studies were carried out on 14C-labeled benzoporphyrin derivative monoacid ring A (BPD), which had been formulated as a unilamellar liposome or taken from a stock solution in dimethyl sulfoxide diluted into phosphate-buffered saline i
Autor:
Julia G. Levy, Alice J. Canaan, Ashok K. Jain, Elizabeth Waterfield, Ethan Sternberg, Anna M. Richter
Publikováno v:
Biochemical Pharmacology. 43:2349-2358
Benzoporphyrin derivative, monoacid ring A (BPD-MA), currently in clinical trials as a photosensitizer for photodynamic therapy for cancer, consists of two regioisomers (A1 and A2) present in equal proportions. The contribution of the regioisomers to
Autor:
Alice J. Canaan, John Robert North, Ethan Sternberg, Anna M. Richter, Angela Cho, Claire Smits, Lina Hong, Ron Boch, David Dolphin, Ashok K. Jain
Publikováno v:
Photochemistry and photobiology. 82(1)
A newly synthesized diethylene glycol functionalized chlorin-type photosensitizer, lemuteporfin, was characterized for use in photodynamic therapy (PDT) in a panel of in vitro and in vivo test systems. The photosensitizer was highly potent, killing c
Autor:
Janice North, Anna M. Richter, Guillermo O. Simkin, Robert D. Bower, Julia G. Levy, Ashok K. Jain, Alice J. Canaan
Publikováno v:
Photochemotherapy: Photodynamic Therapy and Other Modalities III.
Benzoporphyrin derivative monoacid ring A [BPD-MA (verteporfin) or BPD], a second generation photosensitizer tested in clinical trials in combination with red light was compared for its PDT efficiency in vitro and in vivo upon activation with light i
Publikováno v:
SPIE Proceedings.
Skin photosensitivity is the most common side effect of photodynamic therapy (PDT) and in clinical situations needs to be avoided or at least minimized. However, because of the accessibility of skin tissue, skin photosensitivity represents a useful t
Publikováno v:
Proceedings of SPIE.
Uptake and release/retention of the photosensitizer, benzoporphyrin derivative, monoacid ring A (BPD; 1 - 20 (mu) g/mL) was studied using cell lines (K562, L1210) and normal, non- activated and Concanavalin A-activated murine splenocytes. Concentrati
Autor:
R. K. Chowdhary, Meadows Howard E, Alice J. Canaan, Douglas Waterfield, Anna M. Richter, Julia G. Levy, Ashok K. Jain, Leslie G. Ratkay, Modestus Obochi
Publikováno v:
SPIE Proceedings.
Benzoporphyrin derivative monoacid ring A (BPD) is taken up rapidly (within 30 minutes) by most cells. Rapidly dividing tumor cell lines and mitogen activated murine T lymphocytes were found to take up significantly more (5 - 10 fold) BPD than do nor
Autor:
Modestus Obochi, Alice J. Canaan, Julia G. Levy, Meadows Howard E, Anna M. Richter, Ashok K. Jain
Publikováno v:
Photochemistry and photobiology. 59(3)
In vitro experiments with benzoporphyrin derivative monoacid ring A (BPD) confirmed earlier studies that it was taken up rapidly (within 30 min) to maximum concentrations by all cells tested. It was also confirmed that rapidly dividing tumor cell lin